Hyperfine, Inc. (HYPR)

0.8144 +0.02 (+2.32%) USD  |  NASDAQ  |  Sep 25, 16:00
0.8144 0.00 (0.00%) After-Hours: 19:59
More

Hyperfine Research and Development Expense (Annual) : 17.45M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for HYPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 17.45M
December 31, 2024 22.50M
December 31, 2023 22.49M
Date Value
December 31, 2022 28.16M
December 31, 2021 25.84M
December 31, 2020 14.59M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Abbott Laboratories 2.889B
AngioDynamics, Inc. 29.45M
Alphatec Holdings, Inc. 76.27M
AtriCure, Inc. 90.17M
Baxter International, Inc. 503.00M